Treatment of ß-Thalassemia Major With Autologous CD34+ Hematopoietic Progenitor Cells Transduced With Thalagen™, a Lentiviral Vector Encoding the Normal Human ß-Globin Gene
by on Friday, July 13th, 2012 | No Comments
Condition: Confirmed Diagnosis of ß-thalassemia Major
Intervention: Genetic: Autologous CD34+ cells transduced with TNS9.3.55 (Thalagen™)
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Errant Gene Therapeutics
Recruiting – verified July 2012
See the article here: Treatment of ß-Thalassemia Major With Autologous CD34+ Hematopoietic Progenitor Cells Transduced With Thalagen™, a Lentiviral Vector Encoding the Normal Human ß-Globin Gene